Vance Street Capital has announced it has closed its fourth fund, Vance Street Capital IV, with $775 million.

The fund exceeded its target of $550 million in commitments.

Through the new fund, the firm indicated it will continue to pursue businesses in the medical and life science sectors as well as a few others.

Vance Street, based in Los Angeles, is a middle market private equity firm that typically pursues companies with between $3 million and $30 million in EBITDA and with an enterprise value of $30 million to $350 million operating in the United States and Canada.